No CrossRef data available.
Article contents
Colonization with antiseptic tolerant Staphylococcus aureus in children with cancer: a longitudinal study
Published online by Cambridge University Press: 11 September 2025
Abstract
Objective:
In Staphylococcus aureus the qacA/B and smr genes have been associated with elevated MICs to antiseptics with such organisms often termed antiseptic tolerant S. aureus (ATSA). The impact of repeated healthcare or antiseptic exposure on colonization with ATSA is uncertain.
Design:
Prospective longitudinal cohort study.
Setting/Participants:
The high-risk cohort included children with a new diagnosis of malignancy recruited from a pediatric oncology clinic. The low-risk cohort were otherwise healthy children enrolled from general pediatrics clinics.
Methods:
Subjects had anterior nares and axillary cultures collected at 3-month intervals for one year. Identified S. aureus isolates underwent PCR for qacA/B and smr. The primary outcome was colonization with ATSA at least once during study follow-up. Logistic regression models were utilized to adjust for confounding across cohorts.
Results:
226 subjects were evaluable for the primary outcome. It was noted that 93.5% of high-risk subjects reported regularly using chlorhexidine gluconate (CHG) antiseptic products. Colonization with ATSA was found in 15.5% of subjects. In univariable analyses, subjects in the low-risk cohort more frequently had ATSA colonization; following adjustment for confounders, the rates of overall ATSA colonization were similar in the high- and low-risk cohorts. Only 2 subjects had colonization with an ATSA strain at more than one encounter.
Conclusions:
Pediatric oncology patients do not experience higher rates of ATSA colonization than healthy children. In addition, ATSA colonization is transient relative to strains negative for smr/qacA/B. These findings suggest that repeated use of infection prevention strategies including CHG do not predispose to colonization with ATSA in the ambulatory setting.
Information
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Footnotes
Preliminary results from this study were presented at the 2023 American Society for Microbiology ASM Microbe meeting, abstract #3917.
References
Bleasdale, SC, Trick, WE, Gonzalez, IM, Lyles, RD, Hayden, MK, Weinstein, RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073–2079.10.1001/archinte.167.19.2073CrossRefGoogle ScholarPubMed
Climo, MW, Yokoe, DS, Warren, DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533–542.10.1056/NEJMoa1113849CrossRefGoogle ScholarPubMed
DeRiso, AJ, Ladowski, JS, Dillon, TA, Justice, JW, Peterson, AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 1996;109:1556–1561.10.1378/chest.109.6.1556CrossRefGoogle ScholarPubMed
Lee, BY, Bartsch, SM, Wong, KF, et al. Beyond the intensive care unit (ICU): Countywide impact of universal ICU Staphylococcus aureus decolonization. Am J Epidemiol 2016;183:480–489.10.1093/aje/kww008CrossRefGoogle ScholarPubMed
Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: A multicentre, cluster-randomised, crossover trial. Lancet 2013;381:1099–1106.10.1016/S0140-6736(12)61687-0CrossRefGoogle ScholarPubMed
Quach, C, Milstone, AM, Perpete, C, Bonenfant, M, Moore, DL, Perreault, T. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: Impact on central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2014;35:158–163.10.1086/674862CrossRefGoogle Scholar
Toltzis, P, O’Riordan, M, Cunningham, DJ, et al. A statewide collaborative to reduce pediatric surgical site infections. Pediatrics 2014;134:e1174–1180.10.1542/peds.2014-0097CrossRefGoogle ScholarPubMed
Raulji, CM, Clay, K, Velasco, C, Yu, LC. Daily bathing with chlorhexidine and its effects on nosocomial infection rates in pediatric oncology patients. Pediatr Hematol Oncol 2015;32:315–321.10.3109/08880018.2015.1013588CrossRefGoogle ScholarPubMed
Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 1999;20:250–278.10.1086/501620CrossRefGoogle ScholarPubMed
O’Grady, NP, Alexander, M, Burns, LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162–193.10.1093/cid/cir257CrossRefGoogle ScholarPubMed
Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014;35:S21–31.10.1017/S0899823X00193833CrossRefGoogle ScholarPubMed
Blackburn, RM, Henderson, KL, Minaji, M, Meuller-Pedobdy, B, Johnson, AP, Sharland, M. Exploring the epidemioogy of hospital-acquired bloodstream infections in children in England (January 2009- March 2010) by linkage of national hospital admissions and microbiological databases. J Pediatr Infect Dis Soc 2012;1:284–292.10.1093/jpids/pis084CrossRefGoogle Scholar
Wisplinghoff, H, Seifert, H, Tallent, SM, Bischoff, T, Wenzel, RP, Edmond, MB. Nosocomial bloodstream infections in pediatric patients in United States hospitals: Epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003;22:686–691.10.1097/01.inf.0000078159.53132.40CrossRefGoogle ScholarPubMed
McNeil, JC, Kok, EY, Vallejo, JG, et al. Clinical and molecular features of decreased chlorhexidine susceptibility among nosocomial Staphylococcus aureus isolates at Texas Children’s Hospital. Antimicrob Agents Chemother 2015;60:1121–1128.10.1128/AAC.02011-15CrossRefGoogle ScholarPubMed
McNeil, JC, Sommer, LM, Vallejo, JG, Hulten, KG, Kaplan, SL. Association of qacA/B and smr Carriage with Staphylococcus aureus Survival following Exposure to Antiseptics in an Ex Vivo Venous Catheter Disinfection Model. Microbiol Spectr 2023;11:e0333322.10.1128/spectrum.03333-22CrossRefGoogle Scholar
Lee, AS, Macedo-Vinas, M, Francois, P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: A case-control study. Clin Infect Dis 2011;52:1422–1430.10.1093/cid/cir233CrossRefGoogle ScholarPubMed
Batra, R, Cooper, BS, Whiteley, C, Patel, AK, Wyncoll, D, Edgeworth, JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50:210–217.10.1086/648717CrossRefGoogle Scholar
McCullers, JA, Williams, BF, Wu, S, et al. Healthcare-associated infections at a children’s cancer hospital, 1983-2008. J Pediatric Infect Dis Soc 2012;1:26–34.10.1093/jpids/pis034CrossRefGoogle Scholar
McNeil, JC, Hulten, KG, Kaplan, SL, Mahoney, DH, Mason, EO.
Staphylococcus aureus infections in pediatric oncology patients: High rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J 2013;32:124–128.10.1097/INF.0b013e318271c4e0CrossRefGoogle ScholarPubMed
Kuehnert, MJ, Kruszon-Moran, D, Hill, HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006;193:172–179.10.1086/499632CrossRefGoogle ScholarPubMed
McNeil, JC, Flores, AR, Kaplan, SL, Hulten, KG. The indirect impact of the SARS-CoV-2 pandemic on invasive group a Streptococcus, Streptococcus pneumoniae and Staphylococcus aureus infections in houston area children. Pediatr Infect Dis J 2021;40:e313–e316.10.1097/INF.0000000000003195CrossRefGoogle ScholarPubMed
Lautenbach, E, Nachamkin, I, Hu, B, et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: Diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol 2009;30:380–382.10.1086/596045CrossRefGoogle ScholarPubMed
Suwantarat, N, Carroll, KC, Tekle, T, et al. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2014;35:1183–1186.10.1086/677628CrossRefGoogle ScholarPubMed
Warren, DK, Prager, M, Munigala, S, et al. Prevalence of qacA/B genes and Mupirocin resistance among Methicillin-resistant Staphylococcus aureus (MRSA) isolates in the setting of chlorhexidine bathing without Mupirocin. Infect Control Hosp Epidemiol 2016;37:590–597.10.1017/ice.2016.1CrossRefGoogle ScholarPubMed
Reich, PJ, Boyle, MG, Hogan, PG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: An infection prevention and patient safety challenge. Clin Microbiol Infect 2016;22:645 e641–648.Google Scholar
Fritz, SA, Hogan, PG, Camins, BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013;57:559–568.10.1128/AAC.01633-12CrossRefGoogle ScholarPubMed
Schlett, CD, Millar, EV, Crawford, KB, et al. Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure. Antimicrob Agents Chemother 2014;58:4404–4410.10.1128/AAC.02419-14CrossRefGoogle ScholarPubMed
Zerr, DM, Milstone, AM, Dvorak, CC, et al. Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the children’s oncology group. Cancer 2021;127:56–66.10.1002/cncr.33271CrossRefGoogle ScholarPubMed
Fritz, SA, Krauss, MJ, Epplin, EK, et al. The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Pediatr Infect Dis J 2011;30:349–351.10.1097/INF.0b013e3181fe075eCrossRefGoogle ScholarPubMed
Fritz, SA, Garbutt, J, Elward, A, Shannon, W, Storch, GA. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics 2008;121:1090–1098.10.1542/peds.2007-2104CrossRefGoogle Scholar
Engstrom, EE, Plattner, AS, McNeil, JC, et al. Invasive community-onset gram-positive infections from july 2018 through december 2022 at 2 children’s hospitals. Open Forum Infect Dis 2023;10:ofad563.10.1093/ofid/ofad563CrossRefGoogle ScholarPubMed
McNeil, JC, Joseph, M, Sommer, LM, Flores, AR.
Staphylococcus aureus colonization in healthy children during the first year of the severe acute respiratory syndrome coronavirus 2 pandemic. J Pediatr. 2022;249:101–105 e101.10.1016/j.jpeds.2022.06.025CrossRefGoogle ScholarPubMed
Noguchi, N, Hase, M, Kitta, M, Sasatsu, M, Deguchi, K, Kono, M. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus
. FEMS Microbiol Lett 1999;172:247–253.10.1111/j.1574-6968.1999.tb13475.xCrossRefGoogle ScholarPubMed
Nakaminami, H, Noguchi, N, Sasatsu, M. Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus
. Antimicrob Agents Chemother 2010;54:4107–4111.10.1128/AAC.01065-09CrossRefGoogle ScholarPubMed
McNeil, JC, Hulten, KG, Mason, EO, Kaplan, SL. Impact of health care exposure on genotypic antiseptic tolerance in Staphylococcus aureus infections in a pediatric population. Antimicrob Agents Chemother 2017;61:e00223–00217.10.1128/AAC.00223-17CrossRefGoogle Scholar
Mork, RL, Hogan, PG, Muenks, CE, et al. Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: A prospective cohort study. Lancet Infect Dis 2020;20:188–198.10.1016/S1473-3099(19)30570-5CrossRefGoogle ScholarPubMed
Touati, A, Bellil, Z, Barache, D, Mairi, A. Fitness cost of antibiotic resistance in Staphylococcus aureus: A systematic review. Microb Drug Resist 2021;27:1218–1231.10.1089/mdr.2020.0426CrossRefGoogle ScholarPubMed
Rosa, R, de Paula Baptista, R, Tran, TT, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) harboring mupirocin and biocide resistance genes in a large health care system. Am J Infect Control 2025;53:105–109.10.1016/j.ajic.2024.09.002CrossRefGoogle Scholar
Vali, L, Davies, SE, Lai, LL, Dave, J, Amyes, SG. Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates. J Antimicrob Chemother 2008;61:524–532.10.1093/jac/dkm520CrossRefGoogle ScholarPubMed
Liu, Q, Zhao, H, Han, L, Shu, W, Wu, Q, Ni, Y. Frequency of biocide-resistant genes and susceptibility to chlorhexidine in high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA). Diagn Microbiol Infect Dis 2015;82:278–283.10.1016/j.diagmicrobio.2015.03.023CrossRefGoogle ScholarPubMed
McNeil et al. supplementary material 1
McNeil et al. supplementary material
File
37.8 KB
McNeil et al. supplementary material 2
McNeil et al. supplementary material
File
853.9 KB
McNeil et al. supplementary material 3
McNeil et al. supplementary material
File
684.2 KB
McNeil et al. supplementary material 4
McNeil et al. supplementary material
File
751.1 KB